STAT proteins in innate immunity during sepsis: Lessons from gene knockout mice

Acta Medica Okayama

Volumn 61, Issue 5, 2007, Pages 239-245

  Matsukawa, Akihiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cytokines; Innate immunity; Sepsis; SOCS; STAT

Indexed keywords

JANUS KINASE; STAT PROTEIN;

ANIMAL; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; MOUSE; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

ANIMALS; IMMUNITY, NATURAL; JANUS KINASES; MICE; MICE, KNOCKOUT; SEPSIS; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS;

MUS;

EID: 37749038749     PISSN: 0386300X     EISSN: 0386300X     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Fearon DT and Locksley RM: The instructive role of innate immunity in the acquired immune response. Science (1996) 272: 50-53.
2. Hoffmann JA, Kafatos FC, Janeway CA and Ezekowitz RA: Phylogenetic perspectives in innate immunity. Science (1999) 284: 1313-1318.
3. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS and Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA (1995) 273: 117-123.
4. Bellingan G: Leukocytes: friend or foe. Intensive Care Med (2000) 26 Suppl 1: S111-118.
5. Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med (1996) 24: 1125-1128.
6. Hack CE, Aarden LA and Thijs LG: Role of cytokines in sepsis. Adv Immunol (1997) 66: 101-195.
7. O'Shea JJ, Gadina M and Schreiber RD: Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell (2002) 109 Suppl: S121-131.
8. Levy DE and Darnell JEJ: Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol (2002) 3: 651-662.
9. Takeda K and Akira S: STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev (2000) 11: 199-207.
10. Alexander WS and Hilton DJ: The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol (2004) 22: 503-529.
11. Astiz ME and Rackow EC: Septic shock. Lancet (1998) 351: 1501-1505.
12. Bone RC, Sprung CL and Sibbald WJ: Definitions for sepsis and organ failure. Crit Care Med (1992) 20: 724-726.
13. Kellum JA and Decker JM: The immune system: relation to sepsis and multiple organ failure. AACN Clin Issues (1996) 7: 339-350; quiz 459-460.
14. Angus DC and Wax RS: Epidemiology of sepsis: an update. Crit Care Med (2001) 29: S109-116.
15. Holzheimer RG, Muhrer KH, L'Allemand N, Schmidt T and Henneking K: Intraabdominal infections: classification, mortality, scoring and pathophysiology. Infection (1991) 19: 447-452.
16. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM and Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest (1992) 101: 1644-1655.
17. Matsukawa A, Hogaboam CM, Lukacs NW, Lincoln PM, Evanoff HL and Kunkel SL: Pivotal role of the CC chemokine, macrophage-derived chemokine, in the innate immune response. J Immunol (2000) 164: 5362-5368.
18. Matsukawa A, Hogaboam CM, Lukacs NW, Lincoln PM, Strieter RM and Kunkel SL: Endogenous monocyte chemoattractant protein-1 (MCP-1 ) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4. J Immunol (1999) 163: 6148-6154.
19. + T cell responses: the alternative approaches. Annu Rev Immunol (1997) 15: 297-322.
20. Infante-Duarte C and Kamradt T: Th1/Th2 balance in infection. Springer Semin Immunopathol (1999) 21: 317-338.
21. Steinhauser ML, Hogaboam CM, Lukacs NW, Strieter RM and Kunkel SL: Multiple roles for IL-12 in a model of acute septic peritonitis. J Immunol (1999) 162: 5437-5443.
22. Philip R and Epstein LB: Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature (1986) 323: 86-89.
23. Totemeyer S, Sheppard M, Lloyd A, Roper D, Dowson C, Underhill D, Murray P, Maskell D and Bryant C: IFN-gamma enhances production of nitric oxide from macrophages via a mechanism that depends on nucleotide oligomerization domain-2. J Immunol (2006) 176: 4804-4810.
24. Malaviya R, Ikeda T, Ross E and Abraham SN: Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature (1996) 381: 77-80.
25. Matsukawa A, Hogaboam CM, Lukacs NW, Lincoln PM, Evanoff HL, Strieter RM and Kunkel SL: Expression and contribution of endogenous IL-13 in an experimental model of sepsis. J Immunol (2000) 164: 2738-2744.
26. Opal SM and DePalo VA: Anti-inflammatory cytokines. Chest (2000) 117: 1162-1172.
27. van der Poll T, Marchant A, Buurman WA, Berman L, Keogh CV, Lazarus DD, Nguyen L, Goldman M, Moldawer LL and Lowry SF: Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol (1995) 155: 5397-5401.
28. Reich NC and Liu L: Tracking STAT nuclear traffic. Nat Rev Immunol (2006) 6: 602-612.
29. Chen Y, Nakane A and Minagawa T: Recombinant murine gamma interferon induces enhanced resistance to Listeria monocytogenes infection in neonatal mice. Infect Immun (1989) 57: 2345-2349.
30. Kiderlen AF, Kaufmann SH and Lohmann-Matthes ML: Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon. Eur J Immunol (1984) 14: 964-967.
31. Bao S, Beagley KW, France MP, Shen J and Husband AJ: Interferon-gamma plays a critical role in intestinal immunity against Salmonella typhimurium infection. Immunology (2000) 99: 464-472.
32. + TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location. J Immunol (1996) 156: 3321-3326.
33. Nauciel C and Espinasse-Maes F: Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection. Infect Immun (1992) 60: 450-454.
34. Yin K, Gribbin E and Wang H: Interferon-gamma inhibition attenuates lethality after cecal ligation and puncture in rats: implication of high mobility group box-1. Shock (2005) 24: 396-401.
35. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A and Tracey KJ: HMG-1 as a late mediator of endotoxin lethality in mice. Science (1999) 285: 248-251.
36. Car BD, Eng VM, Schnyder B, Ozmen L, Huang S, Gallay P, Heumann D, Aguet M and Ryffel B: Interferon gamma receptor deficient mice are resistant to endotoxic shock. J Exp Med (1994) 179: 1437-1444.
37. Kamezaki K, Shimoda K, Numata A, Matsuda T, Nakayama K and Harada M: The role of Tyk2, Stat1 and Stat4 in LPS-induced endotoxin signals. Int Immunol (2004) 16: 1173-1179.
38. Yao YM, Wang SB, Xian LM, Zhai XZ, Dong N, Yu Y and Sheng ZY: [The potential mechanism on signal transduction pathway in regulation of mRNA expression of high mobility group box-1 protein in septic rats]. Zhonghua Wai Ke Za Zhi (2006) 44: 916-920 (in Chinese).
39. Chmiel JF, Konstan MW, Knesebeck JE, Hilliard JB, Bonfield TL, Dawson DV and Berger M: IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice. Am J Respir Crit Care Med (1999) 160: 2040-2047.
40. Chmiel JF, Konstan MW, Saadane A, Krenicky JE, Lester Kirchner H and Berger M: Prolonged inflammatory response to acute Pseudomonas challenge in interleukin-10 knockout mice. Am J Respir Crit Care Med (2002) 165: 1176-1181.
41. Del Sero G, Mencacci A, Cenci E, d'Ostiani CF, Montagnoli C, Bacci A, Mosci P, Kopf M and Romani L: Antifungal type 1 responses are upregulated in IL-10-deficient mice. Microbes Infect (1999) 1: 1169-1180.
42. Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T and Akira S: Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA (1997) 94: 3801-3804.
43. Riley JK, Takeda K, Akira S and Schreiber RD: Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J Biol Chem (1999) 274: 16513-16521.
44. Matsukawa A, Kudo S, Maeda T, Numata K, Watanabe H, Takeda K, Akira S and lto T: Stat3 in resident macrophages as a repressor protein of inflammatory response. J Immunol (2005) 175: 3354-3359.
45. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Forster I and Akira S: Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity (1999) 10: 39-49.
46. Matsukawa A, Takeda K, Kudo S, Maeda T, Kagayama M and Akira S: Aberrant inflammation and lethality to septic peritonitis in mice lacking STAT3 in macrophages and neutrophils. J Immunol (2003) 171: 6198-6205.
47. Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu CY, Ferrante J, Stewart C, Sarmiento U, Faherty DA and Gately MK: IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity (1996) 4: 471-481.
48. Kaplan MH, Sun YL, Hoey T and Grusby MJ: Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature (1996) 382: 174-177.
49. Chitnis T, Najafian N, Benou C, Salama AD, Grusby MJ, Sayegh MH and Khoury SJ: Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J Clin Invest (2001) 108: 739-747.
50. Kaplan MH, Whitfield JR, Boras DL and Grusby MJ: Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J Immunol (1998) 160: 1850-1856.
51. Matsukawa A, Kaplan MH, Hogaboam CM, Lukacs NW and Kunkel SL: Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis. J Exp Med (2001) 193: 679-688.
52. Lentsch AB, Kato A, Davis B, Wang W, Chao C and Edwards MJ: STAT4 and STAT6 regulate systemic inflammation and protect against lethal endotoxemia. J Clin Invest (2001) 108: 1475-1482.
53. Kaplan MH, Schindler U, Smiley ST and Grusby MJ: Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity (1996) 4: 313-319.
54. Palmer-Crocker RL, Hughes CC and Pober JS: IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain. J Clin Invest (1996) 98: 604-609.
55. Takeda K, Kamanaka M, Tanaka T, Kishimoto T and Akira S: Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J Immunol (1996) 157: 3220-3222.
56. Steinhauser ML, Hogaboam CM, Matsukawa A, Lukacs NW, Strieter RM and Kunkel SL: Chemokine C10 promotes disease resolution and survival in an experimental model of bacterial sepsis. Infect Immun (2000) 68: 6108-6114.
57. Stamm LM, Raisanen-Sokolowski A, Okano M, Russell ME, David JR and Satoskar AR: Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis. J Immunol (1998) 161: 6180-6188.
58. Yasukawa H, Sasaki A and Yoshimura A: Negative regulation of cytokine signaling pathways. Annu Rev Immunol (2000) 18: 143-164.
59. Kinjyo I, Hanada T, Inagaki-Ohara K, Mori H, Aki D, Ohishi M, Yoshida H, Kubo M and Yoshimura A: SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity (2002) 17: 583-591.
60. Nakagawa R, Naka T, Tsutsui H, Fujimoto M, Kimura A, Abe T, Seki E, Sato S, Takeuchi O, Takeda K, Akira S, Yamanishi K, Kawase I, Nakanishi K and Kishimoto T: SOCS-1 participates in negative regulation of LPS responses. Immunity (2002) 17: 677-687.
61. Fang M, Dai H, Yu G and Gong F: Gene delivery of SOCS3 protects mice from lethal endotoxic shock. Cell Mol Immunol (2005) 2: 373-377.
62. Watanabe H, Kubo M, Numata K, Takagi K, Mizuta H, Okada S, lto T and Matsukawa A: Overexpression of suppressor of cytokine signaling-5 in T cells augments innate immunity during septic peritonitis. J Immunol (2006) 177: 8650-8657.